Schonfeld Strategic Advisors LLC Verona Pharma PLC Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

A detailed history of Schonfeld Strategic Advisors LLC transactions in Verona Pharma PLC stock. As of the latest transaction made, Schonfeld Strategic Advisors LLC holds 221,996 shares of VRNA stock, worth $7.74 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

221,996

Previous 260,200 14.68%

Holding current value

$7.74 Million

Previous $4.19 Million 23.32%

% of portfolio

0.02%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$11.48 - $17.02 $438,581 - $650,232	-38,204 Reduced 14.68%	221,996 $3.21 Million
Q1 2024 May 15, 2024	SELL	$15.3 - $20.24 $639,540 - $846,031	-41,800 Reduced 13.84%	260,200 $4.19 Million
Q4 2023 Feb 14, 2024	BUY	$11.94 - $20.47 $1.33 Million - $2.28 Million	111,594 Added 58.61%	302,000 $6 Million
Q3 2023 Nov 14, 2023	SELL	$16.3 - $22.09 $40,929 - $55,467	-2,511 Reduced 1.3%	190,406 $3.1 Million
Q2 2023 Aug 14, 2023	SELL	$19.41 - $23.43 $2.77 Million - $3.35 Million	-142,783 Reduced 42.53%	192,917 $4.08 Million
Q1 2023 May 15, 2023	SELL	$18.06 - $25.27 $1.52 Million - $2.13 Million	-84,097 Reduced 20.03%	335,700 $6.74 Million
Q4 2022 Feb 14, 2023	BUY	$9.84 - $26.13 $3.55 Million - $9.43 Million	360,797 Added 611.52%	419,797 $11 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $19,458 - $63,873	4,700 Added 8.66%	59,000 $603,000
Q2 2022 Aug 15, 2022	SELL	$3.55 - $5.06 $14,555 - $20,746	-4,100 Reduced 7.02%	54,300 $227,000
Q1 2022 May 16, 2022	BUY	$4.82 - $6.98 $1,928 - $2,792	400 Added 0.69%	58,400 $292,000
Q4 2021 Feb 14, 2022	SELL	$3.91 - $7.08 $2,346 - $4,248	-600 Reduced 1.02%	58,000 $390,000
Q3 2021 Nov 16, 2021	BUY	$5.29 - $6.35 $2,116 - $2,540	400 Added 0.69%	58,600 $321,000
Q2 2021 Aug 16, 2021	BUY	$5.72 - $9.09 $9,724 - $15,453	1,700 Added 3.01%	58,200 $381,000
Q1 2021 May 17, 2021	BUY	$7.08 - $9.33 $61,596 - $81,171	8,700 Added 18.2%	56,500 $472,000
Q4 2020 Feb 16, 2021	SELL	$5.51 - $8.11 $37,468 - $55,147	-6,800 Reduced 12.45%	47,800 $334,000
Q3 2020 Nov 16, 2020	BUY	$4.45 - $10.2 $242,970 - $556,920	54,600 New	54,600 $0

Others Institutions Holding VRNA

# of Institutions

142

Shares Held

66.7M

Call Options Held

495K

Put Options Held

486K

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $2.13B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account

Schonfeld Strategic Advisors LLC Verona Pharma PLC Transaction History